Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
Open-market buys, last 90 days
$47,855
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$47,855. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. LEDERMAN SETH +$48K Chief Executive Officer 2 filings
Date Insider Transaction Shares Price Value Owned after
2017-06-20 DAVIDSON STUART Director Grant or award · Stock Option +20,000 20,000
2016-05-27 DAVIDSON STUART Director Grant or award · Restricted Stock Unit +7,500 7,500
2016-02-09 DAVIDSON STUART Director Grant or award · Restricted Stock Unit +7,500 7,500
2015-02-25 DAVIDSON STUART Director Grant or award · Stock Option +5,000 5,000
2015-02-25 DAVIDSON STUART Director Grant or award · Restricted Stock Unit +6,000 6,000
2014-10-29 DAVIDSON STUART Director Grant or award · Stock Option +5,000 5,000
2014-06-17 DAVIDSON STUART Director Grant or award · Stock Option +5,000 5,000
2014-02-11 DAVIDSON STUART Director Grant or award · Stock Option +5,500 5,500
2013-04-26 DAVIDSON STUART Director Conversion +166,667 $0.40 $67K 1,490,716
2013-04-26 DAVIDSON STUART Director Conversion · Warrants −166,667 216,667
2013-02-12 DAVIDSON STUART Director Grant or award · Stock Option +225,000 0

Page 1 of 1 · 11 trades